Amgen, Inc. (AMGN), Regeneron Pharmaceuticals Inc (REGN), NPS Pharmaceuticals, Inc. (NPSP): Can These Biotechs Continue to Climb?
NPS received good news in December when the Food and Drug Administration approved Gattex for treatment of short bowel syndrome, or SBS. However, the stock didn't take off.
